2025 Q4 -tulosraportti
Vain PDF
81 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·3 t sittenTONIGHT: NORWAY VS BRAZIL. EXACTLY LIKE CIRCIO VS THE WORLD. 🇳🇴⚽🧬 Think about it. Little Norway — 5 million people — stands against Brazil tonight. Five-time world champion. Everyone considers us an underdog. The odds say we will lose. 🎰 But we are HERE. We broke through. Senegal, Ivory Coast — defeated. No one thought we'd come this far. 💪 Do you see the parallel? A small Norwegian company with 11 employees, listed on a small stock exchange on the outskirts of the world, stands in the middle of the global race to define the future of RNA medicine. 🧬 Against American giants with billions behind them. Everyone considers us an underdog there too. But look who is already lining up: top-5 pharma. Tcelltech. Acuitas. 🤝 We are not just in the tournament — we are winning games. The beauty of underdogs? No one sees them coming. Until they suddenly stand in the final and the whole world wonders where they came from. 👀 Tonight we cheer for Norway against Brazil. And in the global RNA race? There we cheer for another Norwegian team that plays far above its weight class. 🧱 Go Norway. Go Circio. 🇳🇴🍷 We know what we own. ♟️🧱🍷
Well, if the market is like a football match, it's about luck and bad luck. I personally hope for a bit more substance and less randomness than that for Circio's part. But by all means: Go both! 💥🍾🎉
·4 t sittenInteresting where we are headed over the summer. My technical analysis shows that we will go down over the next 2 months. Not in a straight line, but a bit up and down while it slowly and steadily crabs its way downwards 🦀
Stop yourself. It has been written that the order book is rising slowly but surely. So I have this one at around 14 NOK by the end of 2026
·10 t sittenIt's hard to say how much one dares to invest here 😏
I have a position here and on Avanza. The future will decide if I go in more, there's no reason to rush.
·13 t sitten · MuokattuThis is good for us. Circular Genomics has launched its CircPATH platform after a study in Nature Medicine. They use circular RNA (circRNA) for early detection of Alzheimer's. Although this concerns diagnostics and not Circio's core area (therapy/circVec), this is a massive validation of the entire circRNA field.Many signals are starting to point towards Eli Lilly and Alzheimer now. Circio is in a project with an unknown partner in CNS - AAV gene therapy. Sangamo - Lilly with AAV capsides. Several recent licensing agreements Lilly with Swedish companies technology regarding BBB (blood-brain barrier). Circular Genomics diagnostic technology in Lilly Labs: "Circular RNAs represent a fundamentally new class of brain-derived biomarkers that can provide a comprehensive picture of brain biology", with enormous potential to advance precision medicine in Alzheimer's disease and other neurodegenerative disorders, said Dr. Henrik Zetterberg. "Circular Genomics has built an impressive platform that complements existing approaches with fluid biomarkers and opens new avenues for a better understanding of the dynamic brain processes critical for the pathogenesis and progression of brain diseases. I look forward to contributing my expertise in biomarker validation and clinical translation to help bring this innovative diagnostic to patients who need it." Dr. Zetterberg professor in Gothenburg and on the advisory board for CG. Lilly everywhere. Potential for also preventive treatment of Alzheimer with this diagnostic tool. The market is enormous and Circio is a piece in the treatment solution. What then
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
81 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·3 t sittenTONIGHT: NORWAY VS BRAZIL. EXACTLY LIKE CIRCIO VS THE WORLD. 🇳🇴⚽🧬 Think about it. Little Norway — 5 million people — stands against Brazil tonight. Five-time world champion. Everyone considers us an underdog. The odds say we will lose. 🎰 But we are HERE. We broke through. Senegal, Ivory Coast — defeated. No one thought we'd come this far. 💪 Do you see the parallel? A small Norwegian company with 11 employees, listed on a small stock exchange on the outskirts of the world, stands in the middle of the global race to define the future of RNA medicine. 🧬 Against American giants with billions behind them. Everyone considers us an underdog there too. But look who is already lining up: top-5 pharma. Tcelltech. Acuitas. 🤝 We are not just in the tournament — we are winning games. The beauty of underdogs? No one sees them coming. Until they suddenly stand in the final and the whole world wonders where they came from. 👀 Tonight we cheer for Norway against Brazil. And in the global RNA race? There we cheer for another Norwegian team that plays far above its weight class. 🧱 Go Norway. Go Circio. 🇳🇴🍷 We know what we own. ♟️🧱🍷Well, if the market is like a football match, it's about luck and bad luck. I personally hope for a bit more substance and less randomness than that for Circio's part. But by all means: Go both! 💥🍾🎉
- ·4 t sittenInteresting where we are headed over the summer. My technical analysis shows that we will go down over the next 2 months. Not in a straight line, but a bit up and down while it slowly and steadily crabs its way downwards 🦀Stop yourself. It has been written that the order book is rising slowly but surely. So I have this one at around 14 NOK by the end of 2026
- ·10 t sittenIt's hard to say how much one dares to invest here 😏I have a position here and on Avanza. The future will decide if I go in more, there's no reason to rush.
- ·13 t sitten · MuokattuThis is good for us. Circular Genomics has launched its CircPATH platform after a study in Nature Medicine. They use circular RNA (circRNA) for early detection of Alzheimer's. Although this concerns diagnostics and not Circio's core area (therapy/circVec), this is a massive validation of the entire circRNA field.Many signals are starting to point towards Eli Lilly and Alzheimer now. Circio is in a project with an unknown partner in CNS - AAV gene therapy. Sangamo - Lilly with AAV capsides. Several recent licensing agreements Lilly with Swedish companies technology regarding BBB (blood-brain barrier). Circular Genomics diagnostic technology in Lilly Labs: "Circular RNAs represent a fundamentally new class of brain-derived biomarkers that can provide a comprehensive picture of brain biology", with enormous potential to advance precision medicine in Alzheimer's disease and other neurodegenerative disorders, said Dr. Henrik Zetterberg. "Circular Genomics has built an impressive platform that complements existing approaches with fluid biomarkers and opens new avenues for a better understanding of the dynamic brain processes critical for the pathogenesis and progression of brain diseases. I look forward to contributing my expertise in biomarker validation and clinical translation to help bring this innovative diagnostic to patients who need it." Dr. Zetterberg professor in Gothenburg and on the advisory board for CG. Lilly everywhere. Potential for also preventive treatment of Alzheimer with this diagnostic tool. The market is enormous and Circio is a piece in the treatment solution. What then
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
2025 Q4 -tulosraportti
Vain PDF
81 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·3 t sittenTONIGHT: NORWAY VS BRAZIL. EXACTLY LIKE CIRCIO VS THE WORLD. 🇳🇴⚽🧬 Think about it. Little Norway — 5 million people — stands against Brazil tonight. Five-time world champion. Everyone considers us an underdog. The odds say we will lose. 🎰 But we are HERE. We broke through. Senegal, Ivory Coast — defeated. No one thought we'd come this far. 💪 Do you see the parallel? A small Norwegian company with 11 employees, listed on a small stock exchange on the outskirts of the world, stands in the middle of the global race to define the future of RNA medicine. 🧬 Against American giants with billions behind them. Everyone considers us an underdog there too. But look who is already lining up: top-5 pharma. Tcelltech. Acuitas. 🤝 We are not just in the tournament — we are winning games. The beauty of underdogs? No one sees them coming. Until they suddenly stand in the final and the whole world wonders where they came from. 👀 Tonight we cheer for Norway against Brazil. And in the global RNA race? There we cheer for another Norwegian team that plays far above its weight class. 🧱 Go Norway. Go Circio. 🇳🇴🍷 We know what we own. ♟️🧱🍷Well, if the market is like a football match, it's about luck and bad luck. I personally hope for a bit more substance and less randomness than that for Circio's part. But by all means: Go both! 💥🍾🎉
- ·4 t sittenInteresting where we are headed over the summer. My technical analysis shows that we will go down over the next 2 months. Not in a straight line, but a bit up and down while it slowly and steadily crabs its way downwards 🦀Stop yourself. It has been written that the order book is rising slowly but surely. So I have this one at around 14 NOK by the end of 2026
- ·10 t sittenIt's hard to say how much one dares to invest here 😏I have a position here and on Avanza. The future will decide if I go in more, there's no reason to rush.
- ·13 t sitten · MuokattuThis is good for us. Circular Genomics has launched its CircPATH platform after a study in Nature Medicine. They use circular RNA (circRNA) for early detection of Alzheimer's. Although this concerns diagnostics and not Circio's core area (therapy/circVec), this is a massive validation of the entire circRNA field.Many signals are starting to point towards Eli Lilly and Alzheimer now. Circio is in a project with an unknown partner in CNS - AAV gene therapy. Sangamo - Lilly with AAV capsides. Several recent licensing agreements Lilly with Swedish companies technology regarding BBB (blood-brain barrier). Circular Genomics diagnostic technology in Lilly Labs: "Circular RNAs represent a fundamentally new class of brain-derived biomarkers that can provide a comprehensive picture of brain biology", with enormous potential to advance precision medicine in Alzheimer's disease and other neurodegenerative disorders, said Dr. Henrik Zetterberg. "Circular Genomics has built an impressive platform that complements existing approaches with fluid biomarkers and opens new avenues for a better understanding of the dynamic brain processes critical for the pathogenesis and progression of brain diseases. I look forward to contributing my expertise in biomarker validation and clinical translation to help bring this innovative diagnostic to patients who need it." Dr. Zetterberg professor in Gothenburg and on the advisory board for CG. Lilly everywhere. Potential for also preventive treatment of Alzheimer with this diagnostic tool. The market is enormous and Circio is a piece in the treatment solution. What then
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt